ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ELOX Eloxx Pharmaceuticals Inc

3.82
0.00 (0.00%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Eloxx Pharmaceuticals Inc ELOX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 3.82 09:00:00
始値 安値 高値 終値 前日終値
3.82 3.82
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1620:30GLOBEEloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program..
2024/4/0205:02EDGAR2Form NT 10-K - Notification of inability to timely file Form..
2024/3/3005:11EDGAR2Form 8-K - Current report
2024/3/2203:20EDGAR2Form 25-NSE - Notification filed by national security..
2024/3/1505:30EDGAR2Form 8-K - Current report
2024/3/1400:42GLOBEAlmirall and Eloxx Pharmaceuticals Enter into Exclusive..
2024/1/2706:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2706:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2706:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2706:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2511:44EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/1/2507:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/1/1007:10EDGAR2Form 8-K - Current report
2023/12/2906:11EDGAR2Form 8-K - Current report
2023/11/1406:15GLOBEEloxx Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/10/1706:26EDGAR2Form 8-K - Current report
2023/10/0921:00GLOBEEloxx Pharmaceuticals Reports Additional Confirmation that..
2023/9/2105:05EDGAR2Form 8-K - Current report
2023/9/2102:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/9/1921:00GLOBEEloxx Pharmaceuticals Announces $2 Million Registered Direct..
2023/9/1821:05EDGAR2Form 8-K - Current report
2023/9/1820:00GLOBEEloxx Pharmaceuticals Reports Independent Confirmation of..
2023/9/1606:15EDGAR2Form 8-K - Current report
2023/9/0723:14EDGAR2Form 8-K - Current report
2023/9/0722:00GLOBEEloxx Pharmaceuticals Provides Program Updates on ELX-02 and..
2023/8/3005:32EDGAR2Form 8-K - Current report
2023/8/2205:50EDGAR2Form 8-K - Current report
2023/8/1500:56EDGAR2Form 8-K - Current report
2023/8/1421:30GLOBEEloxx Pharmaceuticals Reports Second Quarter 2023 Financial..
2023/8/1421:00GLOBEEloxx Pharmaceuticals Reports Drug Response in All Patients..
2023/8/1205:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/1205:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0405:01EDGAR2Form 8-K - Current report
2023/8/0322:26GLOBEEloxx Pharmaceuticals Granted Extension by Nasdaq to Regain..
2023/7/1321:43EDGAR2Form 8-K - Current report
2023/7/1022:00GLOBEEloxx Pharmaceuticals Announces Publication Demonstrating..
2023/6/2822:00GLOBEEloxx Pharmaceuticals Key Opinion Leader Event Highlights..
2023/6/2202:30GLOBEEloxx Pharmaceuticals to Host Investor and Analyst Call on..
2023/6/2122:00GLOBEEloxx Pharmaceuticals Highlights Recent Alport Syndrome..
2023/6/1505:53GLOBEEloxx Pharmaceuticals Announces Final Data Assessment from..
2023/6/0621:30GLOBEEloxx Pharmaceuticals Granted Extension by Nasdaq to Regain..
2023/6/0122:10GLOBEAtossa Appoints Life Sciences Financial and Operations..
2023/5/2421:00GLOBEEloxx Pharmaceuticals Intends to Advance ELX-02 into Pivotal..
2023/5/1605:30GLOBEEloxx Pharmaceuticals Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock